Streptococcus pneumoniae serotype 19A: worldwide epidemiology

Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?

(2017) Maria L. Avila-Aguero et al.   Expert Review of Vaccines

Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study

(2017) Motoi Suzuki et al.   LANCET INFECTIOUS DISEASES

Pneumococcal conjugate vaccine use in adults – Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia

(2017) Heather L. Sings   VACCINE

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine

(2016) Sara Tomczyk et al.   CLINICAL INFECTIOUS DISEASES

Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA

(2016) B.J. Metcalf et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned

(2016) Lucia Helena de Oliveira et al.   Expert Review of Vaccines

The Antibody Response Following a Booster With Either a 10- or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early Infancy

(2016) Johannes Trück et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Epidemiology of Invasive Pneumococcal Disease in Bangladeshi Children Before Introduction of Pneumococcal Conjugate Vaccine

(2016) Samir K. Saha et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Opinión del Comité Consultivo de Inmunizaciones Sociedad Chilena de Infectología: Vacuna neumocóccica conjugada en niños y la emergencia de serotipo 19A

(2016) Marcela Potin et al.   Revista Chilena de Infectologia

Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national immunization program

(2016) Marta Moreira et al.   VACCINE

Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine

(2016) Emma J. Best et al.   VACCINE

The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey

(2016) Ahmet Soysal et al.   VACCINE

Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands

(2016) Astrid A.T.M. Bosch et al.   VACCINE

Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil

(2016) Maria-Cristina de C. Brandileone et al.   VACCINE

Pneumococcal carriage in young children after introduction of PCV13 in Hong Kong

(2016) Kate Ching Ching Chan et al.   VACCINE

Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis

(2016) Ana Lucia Andrade et al.   Human Vaccines & Immunotherapeutics

Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study

(2016) Matthew R Moore et al.   Lancet Respiratory Medicine

Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France

(2016) Claire Janoir et al.   Open Forum Infectious Diseases

Effectiveness of the 10-Valent Pneumococcal NontypeableHaemophilus influenzaeProtein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland

(2016) Timo Vesikari et al.   Journal of the Pediatric Infectious Diseases Society

Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data

(2016) Janepsy Diaz et al.   PLoS One

Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review

(2016) Lucia Helena de Oliveira et al.   PLoS One

Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines

(2016) Anne L. Wyllie et al.   Scientific Reports

The influence of Streptococcus pneumoniae nasopharyngeal colonization on the clinical outcome of the respiratory tract infections in preschool children

(2015) Sigita Petraitiene et al.   BMC INFECTIOUS DISEASES

Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction

(2015) François Angoulvant et al.   BMC INFECTIOUS DISEASES

Differential B-Cell Memory Around the 11-Month Booster in Children Vaccinated With a 10- or 13-Valent Pneumococcal Conjugate Vaccine

(2015) Els van Westen et al.   CLINICAL INFECTIOUS DISEASES

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children

(2015) Liset Olarte et al.   CLINICAL INFECTIOUS DISEASES

Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001–2011 survey by the French Pneumococcal Network

(2015) M. Kempf et al.   CLINICAL MICROBIOLOGY AND INFECTION

The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease

(2015) Nicola Principi et al.   Expert Review of Vaccines

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

(2015) Pauline A Waight et al.   LANCET INFECTIOUS DISEASES

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

(2015) Matthew R Moore et al.   LANCET INFECTIOUS DISEASES

Impact of the 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of Streptococcus pneumoniae Among Children Attending Group Daycare in Southeastern France

(2015) Brigitte Dunais et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Impact of the Seven-valent Pneumococcal Conjugate Vaccine on Acute Otitis Media in Japanese Children

(2015) Daiki Ozawa et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Pediatric Invasive Pneumococcal Disease in Taiwan Following a National Catch-up Program With the 13-Valent Pneumococcal Conjugate Vaccine

(2015) Sung-Hsi Wei et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia

(2015) Ankita P. Desai et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia

(2015) Anna Roca et al.   VACCINE

Pneumococcal vaccination coverage among persons ≥65 years—United States, 2013

(2015) Alissa C. O’Halloran et al.   VACCINE

Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children

(2015) Emmanuelle Varon et al.   VACCINE

A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation

(2015) Robert Cohen et al.   VACCINE

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012

(2015) A. Lepoutre et al.   VACCINE

Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease

(2015) Jennifer R. Verani et al.   VACCINE

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada

(2015) Geneviève Deceuninck et al.   VACCINE

A longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine era

(2015) Chiara Mameli et al.   Human Vaccines & Immunotherapeutics

Pneumococcal nasopharyngeal carriage in children

(2015) Shalom Ben-Shimol et al.   Human Vaccines & Immunotherapeutics

Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012

(2015) Andrea C. Farnham et al.   JAMA Pediatrics

Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children – A Population-Based Study

(2015) Jukka Jokinen et al.   PLoS One

Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants

(2015) Alienke J. Wijmenga-Monsuur et al.   PLoS One

Recommendations for Pneumococcal Immunization Outside Routine Childhood Immunization Programs in Western Europe

(2014) Paolo Castiglia   ADVANCES IN THERAPY

Post HocAnalysis of a Randomized Double-Blind Trial of the Correlation of Functional and Binding Antibody Responses Elicited by 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines and Association with Nasopharyngeal Colonization

(2014) Christine Juergens et al.   Clinical and Vaccine Immunology

Near-Elimination of Otitis Media Caused by 13-Valent Pneumococcal Conjugate Vaccine (PCV) Serotypes in Southern Israel Shortly After Sequential Introduction of 7-Valent/13-Valent PCV

(2014) Shalom Ben-Shimol et al.   CLINICAL INFECTIOUS DISEASES

Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality

(2014) Zitta Barrella Harboe et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-NonsusceptibleStreptococcus pneumoniae

(2014) Ron Dagan et al.   JOURNAL OF INFECTIOUS DISEASES

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

(2014) Nick J Andrews et al.   LANCET INFECTIOUS DISEASES

Effects of Vaccination on Invasive Pneumococcal Disease in South Africa

(2014) Anne von Gottberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Direct and Indirect Effects of PCV13 on Nasopharyngeal Carriage of PCV13 Unique Pneumococcal Serotypes in Massachusetts’ Children

(2014) Anita M. Loughlin et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Impact of the 13-valent Pneumococcal Conjugate Vaccine on Chronic Sinusitis Associated With Streptococcus pneumoniae in Children

(2014) Liset Olarte et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Invasive Pneumococcal Disease After Implementation of 13-Valent Conjugate Vaccine

(2014) P.-Y. I. Tam et al.   PEDIATRICS

Age-Dependent Prevalence of Nasopharyngeal Carriage of Streptococcus pneumoniae before Conjugate Vaccine Introduction: A Prediction Model Based on a Meta-Analysis

(2014) Olivier Le Polain de Waroux et al.   PLoS One

Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use

(2014) Jonathan F. Mosser et al.   PLoS One

Serotypes and Genotypes of Invasive Streptococcus pneumoniae Before and After PCV10 Implementation in Southern Brazil

(2014) Juliana Caierão et al.   PLoS One

Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England

(2014) Albert Jan van Hoek et al.   VACCINE

Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children

(2014) Shalom Ben-Shimol et al.   VACCINE

Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies

(2014) Laura L Hammitt et al.   Lancet Global Health

Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study

(2014) Carla Magda Allan S Domingues et al.   Lancet Respiratory Medicine

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012

(2013) Walter H.B. Demczuk et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Expansion of Serotype Coverage in the Universal Pediatric Vaccination Calendar: Short-Term Effects on Age- and Serotype-Dependent Incidence of Invasive Pneumococcal Clinical Presentations in Madrid, Spain

(2013) Juan Picazo et al.   Clinical and Vaccine Immunology

Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial

(2013) Ron Dagan et al.   CLINICAL INFECTIOUS DISEASES

Rapid Decrease of 7-Valent Conjugate Vaccine Coverage for Invasive Pneumococcal Diseases in Pediatric Patients in Japan

(2013) Naoko Chiba et al.   Microbial Drug Resistance

U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination

(2013) Marie R. Griffin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine

(2013) Sheldon L. Kaplan et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Invasive Pneumococcal Disease in Infants Younger Than 90 Days Before and After Introduction of PCV7

(2013) L. Olarte et al.   PEDIATRICS

Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol

(2013) Roman Prymula et al.   VACCINE

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

(2013) Anneke Steens et al.   VACCINE

Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era

(2013) Gianvincenzo Zuccotti et al.   VACCINE

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites

(2013) Daniel R. Feikin et al.   PLOS MEDICINE

Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts

(2013) G. M. Lee et al.   Journal of the Pediatric Infectious Diseases Society

Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine

(2012) William C. Gruber et al.   Annals of the New York Academy of Sciences

Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study

(2012) So Hyun Kim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

(2012) Stephanie R Earnshaw et al.   BMC INFECTIOUS DISEASES

Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults

(2012) Robert W. Frenck et al.   Clinical and Vaccine Immunology

Impact of the 7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Infants Younger Than 90 Days in England and Wales

(2012) S. N. Ladhani et al.   CLINICAL INFECTIOUS DISEASES

Effects of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugate Vaccine on Nasopharyngeal Bacterial Colonization in Young Children: A Randomized Controlled Trial

(2012) M. R. van den Bergh et al.   CLINICAL INFECTIOUS DISEASES

Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines

(2012) T. Q. Tan   CLINICAL MICROBIOLOGY REVIEWS

The fundamental link between pneumococcal carriage and disease

(2012) Birgit Simell et al.   Expert Review of Vaccines

Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000–May 2001) and 10 years after (May 2010–May 2011) introduction of conjugate vaccines for child immunisation in Spain

(2012) Asunción Fenoll et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010

(2012) Koh Cheng Thoon et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Changes in Serotype Distribution and Antibiotic Resistance of Nasopharyngeal Isolates of Streptococcus pneumoniae from Children in Korea, after Optional Use of the 7-Valent Conjugate Vaccine

(2012) Eun Young Cho et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial

(2012) Arto A Palmu et al.   LANCET

Streptococcus pneumoniae – a review of carriage, infection, serotype replacement and vaccination

(2012) Sam Mehr et al.   Paediatric Respiratory Reviews

Impact of 13-valent Pneumococcal Conjugate Vaccine on Pneumococcal Nasopharyngeal Carriage in Children With Acute Otitis Media

(2012) Robert Cohen et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine

(2012) Dolly Sharma et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Long-Term Effects of Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis

(2012) Judith Spijkerman et al.   PLoS One

Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children

(2012) Carlos Castañeda-Orjuela et al.   VACCINE

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales

(2012) Nick J. Andrews et al.   VACCINE

Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002–2010

(2012) Laurens Liesenborghs et al.   VACCINE

Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 years

(2012) Tino F. Schwarz et al.   VACCINE

Association of Serotype-Specific Antibody Concentrations and Functional Antibody Titers with Subsequent Pneumococcal Carriage in Toddlers Immunized with a 9-Valent Pneumococcal Conjugate Vaccine

(2011) Birgit Simell et al.   Clinical and Vaccine Immunology

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands

(2011) David R. Strutton et al.   JOURNAL OF INFECTION

Shifting Genetic Structure of Invasive Serotype 19A Pneumococci in the United States

(2011) Bernard W. Beall et al.   JOURNAL OF INFECTIOUS DISEASES

Serotype replacement in disease after pneumococcal vaccination

(2011) Daniel M Weinberger et al.   LANCET

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

(2011) Elizabeth Miller et al.   LANCET INFECTIOUS DISEASES

Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands

(2011) Menno R. van den Bergh et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Response to Primary and Booster Vaccination With 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Korean Infants

(2011) Chang-Hwi Kim et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Childrenʼs Hospital Through the 7-valent Pneumococcal Conjugate Vaccine Era

(2011) Krow Ampofo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine

(2011) Chen-Yen Kuo et al.   VACCINE

The potential cost-effectiveness of infant pneumococcal vaccines in Australia

(2011) Anthony T. Newall et al.   VACCINE

Evaluación Económica de un Programa de Inmunización Infantil en México Basado en la Vacuna Neumocócica Conjugada 13-Valente

(2011) Emilio Muciño-Ortega et al.   VALUE IN HEALTH

Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease

(2010) Grant A Mackenzie et al.   BMC INFECTIOUS DISEASES

Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

(2010) William P Hausdorff et al.   BMC Pediatrics

Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta‐Analysis

(2010) Daniel M. Weinberger et al.   CLINICAL INFECTIOUS DISEASES

The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes

(2010) Deborah Lehmann et al.   CLINICAL INFECTIOUS DISEASES

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]

(2010) Sean T. Duggan   DRUGS

Association of Serotypes of Streptococcus pneumoniae with Age in Invasive Pneumococcal Disease

(2010) M. Imohl et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Serotype and Genotype Replacement among Macrolide-Resistant Invasive Pneumococci in Adults: Mechanisms of Resistance and Association with Different Transposons

(2010) L. Calatayud et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Nasopharyngeal Carriage of Individual Streptococcus pneumoniae Serotypes During Pediatric Pneumonia as a Means to Estimate Serotype Disease Potential

(2010) David Greenberg et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF THE 10-VALENT PNEUMOCOCCAL NONTYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE COADMINISTERED WITH DTPW-HBV/HIB AND POLIOVIRUS VACCINES

(2010) Nancy Bermal et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children

(2010) S. L. Kaplan et al.   PEDIATRICS

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers

(2010) S. H. Yeh et al.   PEDIATRICS

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

(2010) Dorothee M. Kieninger et al.   VACCINE

Pneumococcal disease caused by serotype 19A: Review of the literature and implications for future vaccine development

(2010) Rene Reinert et al.   VACCINE

Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project

(2010) Hope L. Johnson et al.   PLOS MEDICINE

Evaluation of Pneumococcal Polysaccharide Immunoassays Using a 22F Adsorption Step with Serum Samples from Infants Vaccinated with Conjugate Vaccines

(2009) J. T. Poolman et al.   Clinical and Vaccine Immunology

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines

(2009) Daniel J. Isaacman et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Temporal Analysis of Invasive Pneumococcal Clones from Scotland Illustrates Fluctuations in Diversity of Serotype and Genotype in the Absence of Pneumococcal Conjugate Vaccine

(2009) J. M. Jefferies et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines

(2009) Jacek Wysocki et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity

(2009) Nancy Bermal et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine

(2009) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence

(2009) Daniel M. Weinberger et al.   PLoS Pathogens

Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005

(2008) Matthew R. Moore et al.   JOURNAL OF INFECTIOUS DISEASES

Impact of conjugate pneumococcal vaccines on antibiotic resistance

(2008) Ron Dagan et al.   LANCET INFECTIOUS DISEASES

The rise and fall of bacterial clones: Streptococcus pneumoniae

(2008) Birgitta Henriques-Normark et al.   NATURE REVIEWS MICROBIOLOGY

Effects of Routine Infant Vaccination With the 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization With Streptococcus pneumoniae in Children in Calgary, Canada

(2008) James D. Kellner et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Childhood invasive pneumococcal disease in Germany between 1997 and 2003: Variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination

(2008) Simon Rückinger et al.   VACCINE